Top Biotechnology companies in United States by Price to Earnings Ratio (P/E)

This ranking features the top 499 Biotechnology companies in United States ranked by Price to Earnings Ratio (P/E), averaging a Price to Earnings Ratio (P/E) of -3.59, for January 15, 2025.

United States

Biotechnology

#	Name	Price to Earnings Ratio (P/E)	Reported Date	Stock Price	Change	Country
1	Gilead Sciences, Inc. 1 GILD	900.08	Jan. 14, 2025	USD 91.00	1.18%	United States
2	Vericel Corporation 2 VCEL	816.19	Jan. 14, 2025	USD 58.67	-1.59%	United States
3	First Advantage Corporation 3 FA	605.65	Jan. 14, 2025	USD 17.21	-1.54%	United States
4	Incyte Corporation 4 INCY	426.62	Jan. 14, 2025	USD 71.93	-0.61%	United States
5	ChromaDex Corporation 5 CDXC	279.56	Jan. 14, 2025	USD 5.44	3.42%	United States
6	Globus Medical, Inc. 6 GMED	131.21	Jan. 14, 2025	USD 88.18	1.15%	United States
7	Castle Biosciences, Inc. 7 CSTL	117.38	Jan. 14, 2025	USD 25.46	-2.64%	United States
8	Sarepta Therapeutics, Inc. 8 SRPT	93.16	Jan. 14, 2025	USD 118.83	0.34%	United States
9	Dynavax Technologies Corporation 9 DVAX	80.11	Jan. 14, 2025	USD 12.48	NA	United States
10	Bio-Techne Corporation 10 TECH	78.79	Jan. 14, 2025	USD 74.73	-2.21%	United States
11	Krystal Biotech, Inc. 11 KRYS	78.33	Jan. 14, 2025	USD 142.64	-5.10%	United States
12	MannKind Corporation 12 MNKD	77.11	Jan. 14, 2025	USD 6.03	-1.63%	United States
13	Rigel Pharmaceuticals, Inc. 13 RIGL	75.75	Jan. 14, 2025	USD 16.69	-2.46%	United States
14	Simulations Plus, Inc. 14 SLP	70.71	Jan. 14, 2025	USD 28.76	-0.48%	United States
15	TransMedics Group, Inc. 15 TMDX	64.31	Jan. 14, 2025	USD 62.54	-2.36%	United States
16	AbbVie Inc. 16 ABBV	60.57	Jan. 14, 2025	USD 175.55	-0.67%	United States
17	Corteva, Inc. 17 CTVA	60.21	Jan. 14, 2025	USD 60.89	1.60%	United States
18	ADMA Biologics, Inc. 18 ADMA	56.62	Jan. 14, 2025	USD 16.32	-1.03%	United States
19	Revvity, Inc. 19 RVTY	53.03	Jan. 14, 2025	USD 120.73	-1.61%	United States
20	Sotera Health Company 20 SHC	51.09	Jan. 14, 2025	USD 12.76	-2.52%	United States
21	Avantor, Inc. 21 AVTR	47.75	Jan. 14, 2025	USD 21.72	-1.36%	United States
22	DexCom, Inc. 22 DXCM	45.42	Jan. 14, 2025	USD 79.17	-0.84%	United States
23	Ligand Pharmaceuticals Incorporated 23 LGND	45.33	Jan. 14, 2025	USD 108.55	2.54%	United States
24	Laboratory Corporation of America Holdings 24 LH	45.04	Jan. 14, 2025	USD 234.50	0.17%	United States
25	Danaher Corporation 25 DHR	44.10	Jan. 14, 2025	USD 237.62	-0.94%	United States
26	Balchem Corporation 26 BCPC	42.43	Jan. 14, 2025	USD 158.62	1.47%	United States
27	Stryker Corporation 27 SYK	38.53	Jan. 14, 2025	USD 362.80	0.50%	United States
28	Corcept Therapeutics Incorporated 28 CORT	38.31	Jan. 14, 2025	USD 51.66	1.18%	United States
29	BioMarin Pharmaceutical Inc. 29 BMRN	37.73	Jan. 14, 2025	USD 63.81	-4.75%	United States
30	Pfizer Inc. 30 PFE	35.13	Jan. 14, 2025	USD 26.41	-1.46%	United States
31	Thermo Fisher Scientific Inc. 31 TMO	34.72	Jan. 14, 2025	USD 556.99	0.27%	United States
32	Amgen Inc. 32 AMGN	33.94	Jan. 14, 2025	USD 267.10	-1.14%	United States
33	Agilent Technologies, Inc. 33 A	31.78	Jan. 14, 2025	USD 143.43	1.04%	United States
34	Zoetis Inc. 34 ZTS	30.53	Jan. 14, 2025	USD 164.41	-1.15%	United States
35	Bruker Corporation 35 BRKR	30.46	Jan. 14, 2025	USD 61.26	-2.69%	United States
36	biote Corp. 36 BTMD	29.78	Jan. 14, 2025	USD 5.67	2.35%	United States
37	IQVIA Holdings Inc. 37 IQV	25.57	Jan. 14, 2025	USD 197.96	-3.26%	United States
38	OraSure Technologies, Inc. 38 OSUR	24.08	Jan. 14, 2025	USD 3.67	-0.81%	United States
39	Ironwood Pharmaceuticals, Inc. 39 IRWD	23.38	Jan. 14, 2025	USD 3.65	-3.18%	United States
40	Charles River Laboratories International, Inc. 40 CRL	22.04	Jan. 14, 2025	USD 178.08	-6.34%	United States
41	ACADIA Pharmaceuticals Inc. 41 ACAD	21.88	Jan. 14, 2025	USD 16.90	-5.59%	United States
42	Exelixis, Inc. 42 EXEL	21.80	Jan. 14, 2025	USD 35.65	0.99%	United States
43	Catalyst Pharmaceuticals, Inc. 43 CPRX	18.53	Jan. 14, 2025	USD 22.19	-0.09%	United States
44	Eledon Pharmaceuticals, Inc. 44 ELDN	18.25	Jan. 14, 2025	USD 3.71	-4.63%	United States
45	Halozyme Therapeutics, Inc. 45 HALO	17.45	Jan. 14, 2025	USD 53.83	-0.57%	United States
46	Harmony Biosciences Holdings, Inc. 46 HRMY	16.94	Jan. 14, 2025	USD 36.42	-0.08%	United States
47	Regeneron Pharmaceuticals, Inc. 47 REGN	16.31	Jan. 14, 2025	USD 690.87	-3.63%	United States
48	Royalty Pharma plc 48 RPRX	15.45	Jan. 14, 2025	USD 30.03	0.13%	United States
49	Lantheus Holdings, Inc. 49 LNTH	15.06	Jan. 14, 2025	USD 92.62	-2.15%	United States
50	United Therapeutics Corporation 50 UTHR	14.66	Jan. 14, 2025	USD 364.70	0.50%	United States

1 2 3 4 … 10

Frequently Asked Questions

Which Biotechnology company in United States has the highest Price to Earnings Ratio (P/E) ?

The Biotechnology company in United States with the highest Price to Earnings Ratio (P/E) is Gilead Sciences, Inc. (NasdaqGS: GILD) at 900.08.
Which Biotechnology company in United States has the lowest Price to Earnings Ratio (P/E) ?

The Biotechnology company in United States with the lowest Price to Earnings Ratio (P/E) is Artivion, Inc. (NYSE: AORT) at -1,468.93.

What are the top 10 Biotechnology companies in United States by Price to Earnings Ratio (P/E) ?

The top 10 Biotechnology companies in United States by Price to Earnings Ratio (P/E) are Gilead Sciences, Inc., Vericel Corporation, First Advantage Corporation, Incyte Corporation, ChromaDex Corporation, Globus Medical, Inc., Castle Biosciences, Inc., Sarepta Therapeutics, Inc., Dynavax Technologies Corporation and Bio-Techne Corporation.
What are the bottom 10 Biotechnology companies in United States by Price to Earnings Ratio (P/E) ?

The bottom 10 Biotechnology companies in United States by Price to Earnings Ratio (P/E) are Artivion, Inc., Repligen Corporation, Coherus BioSciences, Inc., Veracyte, Inc., TG Therapeutics, Inc., Champions Oncology, Inc., Vertex Pharmaceuticals Incorporated, ANI Pharmaceuticals, Inc., Intra-Cellular Therapies, Inc. and JUPITER NEUROSCIENCES, INC..